Loring Wolcott & Coolidge Fiduciary Advisors’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-51
Closed -$5K 623
2014
Q1
$5K Buy
+51
New +$3.97K ﹤0.01% 583

Other funds holding HHS

Loring Wolcott & Coolidge Fiduciary Advisors's HHS Position: Q2 2014 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Harte-Hanks (HHS) in Q2 2014, closing a stake of 51 shares — an estimated $5K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HHS in Q1 2014 and held it in 1 quarter. The position peaked at $5K in Q1 2014. 121 funds tracked by Wall St. Rank hold HHS as of Q2 2014.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Harte-Hanks position as of Q2 2014 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 51 Harte-Hanks shares in Q2 2014, an estimated $5K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Harte-Hanks in Q1 2014 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Harte-Hanks position peaked at $5K in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2014.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2014, filed 12 Aug 2014.